Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.१९%
१,०६६.२१
-२.०३
-०.१९%
—१,०६८.२४१,०६७.९२१,०७७.०७१,०६३.७७——
SIXC
Communications
SIXC
Communications
SIXC
+०.७५%
६११.१६
+४.५७
+०.७५%
—६०६.५९६०६.५९६१५.६८६०५.८२——
SIXE
Energy
SIXE
Energy
SIXE
+१.८२%
१,२६९.९३
+२२.७२
+१.८२%
—१,२४७.२११,२४४.२८१,२७२.८२१,२३१.७७——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.४२%
१,७२०.४१
-७.१७
-०.४२%
—१,७२७.५८१,७२७.१२१,७२७.७५१,७०८.६३——
SIXM
Financials
SIXM
Financials
SIXM
+१.२१%
६३७.१३
+७.५९
+१.२१%
—६२९.५४६२८.८७६३७.९०६२८.४६——
SIXR
Staples
SIXR
Staples
SIXR
+१.४८%
८६६.२५
+१२.६५
+१.४८%
—८५३.६०८५४.४०८६६.५५८५४.०६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+१.२३%
२१४.६४
+२.६०
+१.२३%
—२१२.०४२१२.०४२१४.८६२१२.०४——
SIXT
Technology
SIXT
Technology
SIXT
-१.०९%
३,५११.१३
-३८.६३
-१.०९%
—३,५४९.७६३,५७१.०६३,५७९.२५३,४६१.८९——
SIXU
Utilities
SIXU
Utilities
SIXU
+०.०५%
८८६.९२
+०.४३
+०.०५%
—८८६.४९८८८.५९८९१.९५८७८.९२——
SIXV
Health care
SIXV
Health care
SIXV
+०.४२%
१,४७०.४९
+६.१५
+०.४२%
—१,४६४.३४१,४६०.४४१,४७१.४३१,४५५.१६——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.१९%
२,३४९.७७
-४.४८
-०.१९%
—२,३५४.२५२,३५२.६८२,३७९.५४२,३३४.७६——
GENB:NASDAQ
Generate Biomedicines Inc
US$ १३.००
-१८.७२%
(-३.००) 1D
US$ १३.६०
+४.५८% (+०.६०)
After hours
Closed: मे १८, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GENB...
Open
US$ १५.२५
High
US$ १५.६८
Low
US$ १२.७८
Mkt. cap
१.६७ अरब
Avg. vol.
३.६४ लाख
Volume
१८.११ लाख
52-wk high
US$ १६.७५
52-wk low
US$ ११.००
EPS
-US$ १.९६
No. of employees
३१२
News stories
From sources across the web
Quiver Quantitative
Quiver Quantitative
·
८ घण्टा पहिले
$GENB stock is down 17% today. Here's what we see in our data.
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees३१२
Founded२०१८
HeadquartersSomerville, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websitegeneratebiomedicines.com
Last report
२०२६ मे ७
Fiscal Period
Q1 2026
EPS / Est. (USD)
-US$ १.०७ / -US$ ०.४८
-१२०.६२%miss
Revenue / Est. (USD)
७२.२४ लाख / ४६.८८ लाख
+५४.११%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ मार्च
२०२६ मार्च
Revenue
८८.१८ लाख
७२.२४ लाख
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
४.६८ करोड
५.७८ करोड
Total research and development expenses
-
-
Selling, general, and admin expenses
१.०१ करोड
१.३५ करोड
Operating expense
५.७० करोड
७.१३ करोड
Total operating expenses
५.७० करोड
७.१३ करोड
Operating income
-४.८२ करोड
-६.४१ करोड
Other non operating income
-
-३.६३ लाख
EBT including unusual items
-४.४३ करोड
-६.१७ करोड
EBT excluding unusual items
-४.४३ करोड
-६.१७ करोड
Income tax expense
५६.०० हजार
२८.०० हजार
Effective tax rate
-०.१३%
-०.०५%
Other operating expenses
-
-
Net income
-४.१७ करोड
-६.१४ करोड
Net profit margin
-४७२.७३%
-८५०.५८%
Earnings per share
-
-१.०७
Interest and investment income
४२.८१ लाख
२९.१३ लाख
Interest expense
-३.६८ लाख
-१.८२ लाख
Net interest expenses
३९.१३ लाख
२७.३१ लाख
Depreciation and amortization charges
-
-
EBITDA
-४.४७ करोड
-६.०८ करोड
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer